Skip to main content
. 2020 Apr 28;6(1):e000987. doi: 10.1136/rmdopen-2019-000987

Figure 1.

Figure 1

Study schema. DB, double-blind; EOW, every other week; F, FKB327; OLE, open-label extension; R, randomisation; RA, rheumatoid arthritis; RP, reference product; SC, subcutaneous; w, week. *All patients (except US) were introduced to the FKB327 auto-injector during Period 3.